Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) Versus Albumin Solution for Volume Replacement in Patients After Cardiac Surgery

NCT01418521 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT01418521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01418521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of a Balanced 3rd Generation HES Solution (Tetraspan®) Versus Albumin Solution for Volume Replacement in Patients After Cardiac Surgery
Lead sponsor
Rambam Health Care Campus
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2011
Completion date
August 31, 2013
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elective cardiac surgery